Systemic Therapy for Plaque Psoriasis

Italian guidelines on the systemic treatments of moderate‐to‐severe ...

Recommendations on the treatment of psoriasis in special patient populations were agreed and the use, screening and monitoring of systemic therapies were ...

Comparison of risankizumab and apremilast for the treatment of ...

In this study, patients with moderate plaque psoriasis eligible for systemic therapy and treated with risankizumab showed superior efficacy outcomes to those ...

Trends in Systemic Psoriasis Treatment Therapies from 1993 ...

Oral systemic medications, namely methotrexate, were found to be the most common treatments for beneficiaries receiving therapies used for ...

Treatment for Plaque Psoriasis | Otezla® (apremilast)

VIEW OTEZLA COVERAGE · Plaque psoriasis is a chronic systemic disease that may benefit from a systemic therapy · Otezla has real-world data highlighting the ...

Tildrakizumab for treating plaque psoriasis (after systemic therapy ...

To appraise the clinical and cost effectiveness of tildrakizumab within its marketing authorisation for treating moderate to severe plaque psoriasis.

Targeted systemic therapies for psoriatic arthritis - RMD Open

Randomised controlled trials (RCTs) have compared biological and targeted systemic disease-modifying antirheumatic drugs (DMARDS) against placebo in psoriatic ...

Corporate news details - Bristol Myers Squibb

... (TYK2) inhibitor for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy. The CHMP.

Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris

Treatment of adults with severe plaque-type psoriasis who did not experience therapeutic success with UVB and PUVA or one of the following ...

Sotyktu | European Medicines Agency (EMA)

Two main studies involving 1,686 patients with moderate to severe plaque psoriasis compared Sotyktu with placebo (a dummy treatment) and apremilast, another ...

French guidelines on the use of systemic treatments for moderate‐to ...

therapies, were also generated for the treatment of plaque psoriasis and psoriatic arthritis, together with recommendations ... severe psoriasis warranting ...

Checklist for the Systemic Treatment of Psoriasis Using Biologics

Moderate to severe psoriasis can often be managed using traditional treatments including phototherapy, retinoids, cyclosporine, or methotrexate.

Combination therapies in psoriasis - JournalAgent

systemic treatment of psoriasis vulgaris. ... Gisondi P, Del Giglio M, Cotena C, Girolomoni G: Combining etanercept and acitretin in the therapy of chronic plaque ...

Patient Comorbidities and Severity of Psoriasis Correlate With ...

Several factors influence the choice of prescription systemic therapies for plaque psoriasis, with comorbidities and disease severity ...

Living Systematic Review: Pharmacological treatments for psoriasis ...

There is currently no cure for psoriasis, but various treatments can help to control the symptoms; thus, long-term treatment is usually needed.

Drugs for Plaque Psoriasis | The Medical Letter Inc.

... plaque psoriasis can be treated with topical drugs and phototherapy. Patients with moderate to severe disease generally require systemic therapy ...

Methotrexate versus Cyclosporine in Moderate-to-Severe Chronic ...

Methotrexate and cyclosporine are well-known systemic therapies for moderate-to-severe chronic plaque psoriasis. We conduced a randomized, controlled trial ...

Patients' and Physicians' Preferences for Systemic Psoriasis ...

Psoriasis has a prevalence of 2–3% in Northern countries. Approximately 20% of patients have moderate-to-severe psoriasis and require systemic ...

study protocol for a prospective observational study | BMJ Open

1 2 In this observational study, the systemic second-line therapy with methotrexate, apremilast and fumaric acid esters is evaluated. Methotrexate has been used ...

Plaque Psoriasis (PsO) Treatment | Otezla® (apremilast)

Otezla ® (apremilast) is a prescription medicine used for the treatment of: Adult patients with plaque psoriasis for whom phototherapy or systemic therapy is ...

Treating Psoriasis Vulgaris - U.S. Pharmacist

The newest systemic treatment for plaque psoriasis is the tyrosine kinase 2 (TYK2) inhibitor deucravacitinib. TYK2 inhibitors work by inhibiting ...